<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>0</Volume>
      <Issue>0</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>10</Month>
        <Day>04</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association of Circulating Inflammatory Cytokines IL-6, TNF-&#x3B1;,  and Fibroblast Growth Factor 2 with Disease Progression and Clinical Outcomes in Acute Kidney Injury</title>
    <FirstPage>1</FirstPage>
    <LastPage>13</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Yabin</FirstName>
        <LastName>Zhang</LastName>
        <affiliation locale="en_US">Department of Nephrology, The Second Medical Center of Chinese PLA General Hospital, Beijing, China</affiliation>
      </Author>
      <Author>
        <FirstName>Qiangguo</FirstName>
        <LastName>Ao</LastName>
        <affiliation locale="en_US">Department of Nephrology, The Second Medical Center of Chinese PLA General Hospital, Beijing, China</affiliation>
      </Author>
      <Author>
        <FirstName>Mengkun</FirstName>
        <LastName>Li</LastName>
        <affiliation locale="en_US">Department of Nephrology, The Second Medical Center of Chinese PLA General Hospital, Beijing, China</affiliation>
      </Author>
      <Author>
        <FirstName>Xuwei</FirstName>
        <LastName>He</LastName>
        <affiliation locale="en_US">Department of Nephrology, The Second Medical Center of Chinese PLA General Hospital, Beijing, China</affiliation>
      </Author>
      <Author>
        <FirstName>Qingli</FirstName>
        <LastName>Cheng</LastName>
        <affiliation locale="en_US">Department of Nephrology, The Second Medical Center of Chinese PLA General Hospital, Beijing, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2026</Year>
        <Month>05</Month>
        <Day>09</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2026</Year>
        <Month>06</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Acute kidney injury (AKI) presents challenges for early risk stratification due to its rapid progression and variable outcomes. This study investigated the predictive value of serum interleukin-6 (IL-6), tumor necrosis factor-&#x3B1; (TNF-&#x3B1;), and fibroblast growth factor 2 (FGF-2) for disease progression and clinical outcomes in 104 AKI patients.
Serum biomarkers were measured at diagnosis. Disease progression (worsening of AKI stage) and 28-day major adverse kidney events (MAKE) were assessed.
IL-6 and TNF-&#x3B1; positively correlated with progression and MAKE, while FGF-2 showed negative correlations. Multivariate logistic regression identified IL-6 (aOR=1.034) and TNF-&#x3B1; (aOR=1.082) as independent predictors of progression, but not FGF-2. Cox regression showed TNF-&#x3B1; independently predicted earlier MAKE (aHR=1.031), whereas FGF-2 predicted delayed MAKE (aHR=0.832). IL-6 did not independently affect time to MAKE. The combined biomarker model achieved an AUC of 0.962 for predicting MAKE. Day-of-diagnosis measurement of IL-6, TNF-&#x3B1;, and FGF-2 is significantly associated with AKI progression and adverse outcomes, independent of traditional risk factors.
Evaluating the balance between inflammation and repair may improve risk stratification. The combination of elevated IL-6 and TNF-&#x3B1; with decreased FGF-2 could identify a high-risk phenotype.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4830</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/4830/2431</pdf_url>
  </Article>
</Articles>
